NCT01858883 2019-07-18Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid TumorsIncyte CorporationPhase 1/2 Completed55 enrolled
NCT01822756 2018-02-12An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid TumorsIncyte CorporationPhase 1 Terminated42 enrolled 14 charts